157 related articles for article (PubMed ID: 26589243)
1. Effects of lisdexamfetamine in a rat model of binge-eating.
Vickers SP; Hackett D; Murray F; Hutson PH; Heal DJ
J Psychopharmacol; 2015 Dec; 29(12):1290-307. PubMed ID: 26589243
[TBL] [Abstract][Full Text] [Related]
2. Lisdexamfetamine suppresses instrumental and consummatory behaviors supported by foods with varying degrees of palatability: Exploration of a binge-like eating model.
Presby RE; Rotolo RA; Yang JH; Correa M; Salamone JD
Pharmacol Biochem Behav; 2020 Feb; 189():172851. PubMed ID: 31931017
[TBL] [Abstract][Full Text] [Related]
3. Investigation of impulsivity in binge-eating rats in a delay-discounting task and its prevention by the d-amphetamine prodrug, lisdexamfetamine.
Vickers SP; Goddard S; Brammer RJ; Hutson PH; Heal DJ
J Psychopharmacol; 2017 Jun; 31(6):784-797. PubMed ID: 28372478
[TBL] [Abstract][Full Text] [Related]
4. Lisdexamfetamine reduces the compulsive and perseverative behaviour of binge-eating rats in a novel food reward/punished responding conflict model.
Heal DJ; Goddard S; Brammer RJ; Hutson PH; Vickers SP
J Psychopharmacol; 2016 Jul; 30(7):662-75. PubMed ID: 27170676
[TBL] [Abstract][Full Text] [Related]
5. Baclofen, raclopride, and naltrexone differentially affect intake of fat and sucrose under limited access conditions.
Corwin RL; Wojnicki FH
Behav Pharmacol; 2009 Sep; 20(5-6):537-48. PubMed ID: 19724193
[TBL] [Abstract][Full Text] [Related]
6. Lisdexamfetamine Dimesylate Effects on Binge Eating Behaviour and Obsessive-Compulsive and Impulsive Features in Adults with Binge Eating Disorder.
McElroy SL; Mitchell JE; Wilfley D; Gasior M; Ferreira-Cornwell MC; McKay M; Wang J; Whitaker T; Hudson JI
Eur Eat Disord Rev; 2016 May; 24(3):223-31. PubMed ID: 26621156
[TBL] [Abstract][Full Text] [Related]
7. Baclofen reduces fat intake under binge-type conditions.
Buda-Levin A; Wojnicki FH; Corwin RL
Physiol Behav; 2005 Sep; 86(1-2):176-84. PubMed ID: 16140347
[TBL] [Abstract][Full Text] [Related]
8. The Effects of the Monoamine Stabilizer (-)-OSU6162 on Binge-Like Eating and Cue-Controlled Food-Seeking Behavior in Rats.
Feltmann K; Giuliano C; Everitt BJ; Steensland P; Alsiö J
Neuropsychopharmacology; 2018 Feb; 43(3):617-626. PubMed ID: 28895569
[TBL] [Abstract][Full Text] [Related]
9. Dopamine and μ-opioid receptor dysregulation in the brains of binge-eating female rats - possible relevance in the psychopathology and treatment of binge-eating disorder.
Heal DJ; Hallam M; Prow M; Gosden J; Cheetham S; Choi YK; Tarazi F; Hutson P
J Psychopharmacol; 2017 Jun; 31(6):770-783. PubMed ID: 28376679
[TBL] [Abstract][Full Text] [Related]
10. Relatively enriched housing conditions delay binge onset but do not attenuate binge size.
Preston KE; Corwin RL; Bader JO; Crimmins SL
Physiol Behav; 2018 Feb; 184():196-204. PubMed ID: 29155246
[TBL] [Abstract][Full Text] [Related]
11. The effects in rats of lisdexamfetamine in combination with olanzapine on mesocorticolimbic dopamine efflux, striatal dopamine D2 receptor occupancy and stimulus generalization to a D-amphetamine cue.
Hutson PH; Rowley HL; Gosden J; Kulkarni RS; Slater N; Love PL; Wang Y; Heal D
Neuropharmacology; 2016 Feb; 101():24-35. PubMed ID: 26384654
[TBL] [Abstract][Full Text] [Related]
12. Baclofen, raclopride, and naltrexone differentially reduce solid fat emulsion intake under limited access conditions.
Rao RE; Wojnicki FH; Coupland J; Ghosh S; Corwin RL
Pharmacol Biochem Behav; 2008 Jun; 89(4):581-90. PubMed ID: 18353432
[TBL] [Abstract][Full Text] [Related]
13. Acute methylphenidate treatments reduce sucrose intake in restricted-fed bingeing rats.
Bello NT; Hajnal A
Brain Res Bull; 2006 Oct; 70(4-6):422-9. PubMed ID: 17027778
[TBL] [Abstract][Full Text] [Related]
14. Opioid-dependent anticipatory negative contrast and binge-like eating in rats with limited access to highly preferred food.
Cottone P; Sabino V; Steardo L; Zorrilla EP
Neuropsychopharmacology; 2008 Feb; 33(3):524-35. PubMed ID: 17443124
[TBL] [Abstract][Full Text] [Related]
15. 2-Hydroxyestradiol enhances binge onset in female rats and reduces prefrontal cortical dopamine in male rats.
Babbs RK; Unger EL; Corwin RL
Horm Behav; 2013 Jan; 63(1):88-96. PubMed ID: 23116652
[TBL] [Abstract][Full Text] [Related]
16. GS 455534 selectively suppresses binge eating of palatable food and attenuates dopamine release in the accumbens of sugar-bingeing rats.
Bocarsly ME; Hoebel BG; Paredes D; von Loga I; Murray SM; Wang M; Arolfo MP; Yao L; Diamond I; Avena NM
Behav Pharmacol; 2014 Apr; 25(2):147-57. PubMed ID: 24603339
[TBL] [Abstract][Full Text] [Related]
17. Lisdexamfetamine: chemistry, pharmacodynamics, pharmacokinetics, and clinical efficacy, safety, and tolerability in the treatment of binge eating disorder.
Ward K; Citrome L
Expert Opin Drug Metab Toxicol; 2018 Feb; 14(2):229-238. PubMed ID: 29258368
[TBL] [Abstract][Full Text] [Related]
18. Extended vs. brief intermittent access to palatable food differently promote binge-like intake, rejection of less preferred food, and weight cycling in female rats.
Kreisler AD; Garcia MG; Spierling SR; Hui BE; Zorrilla EP
Physiol Behav; 2017 Aug; 177():305-316. PubMed ID: 28366814
[TBL] [Abstract][Full Text] [Related]
19. Effect of chronic administration of tamoxifen and/or estradiol on feeding behavior, palatable food and metabolic parameters in ovariectomized rats.
Lampert C; Arcego DM; Laureano DP; Diehl LA; da Costa Lima IF; Krolow R; Pettenuzzo LF; Dalmaz C; Vendite D
Physiol Behav; 2013 Jul; 119():17-24. PubMed ID: 23688948
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of opioid transmission at the μ-opioid receptor prevents both food seeking and binge-like eating.
Giuliano C; Robbins TW; Nathan PJ; Bullmore ET; Everitt BJ
Neuropsychopharmacology; 2012 Nov; 37(12):2643-52. PubMed ID: 22805601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
